Alpha DNA Investment Management’s Cirrus Logic CRUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,366
Closed -$335K 51
2024
Q4
$335K Buy
3,366
+51
+2% +$5.6K 0.13% 183
2024
Q3
$412K Buy
+3,315
New +$439K 0.15% 164
2022
Q3
Sell
-13,905
Closed -$1.01M 161
2022
Q2
$1.01M Buy
+13,905
New +$1.08M 0.86% 54
2021
Q4
Sell
-17,122
Closed -$1.41M 116
2021
Q3
$1.41M Buy
+17,122
New +$1.42M 0.96% 56
2021
Q1
Sell
-1,572
Closed -$129K 705
2020
Q4
$129K Buy
+1,572
New +$118K 0.14% 122

Other funds holding CRUS

Alpha DNA Investment Management's CRUS Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Cirrus Logic (CRUS) in Q1 2025, closing a stake of 3,366 shares — an estimated $335K sold.

Alpha DNA Investment Management first reported a position in CRUS in Q4 2020 and held it in 5 quarters. The position peaked at $1.41M in Q3 2021. 436 funds tracked by Wall St. Rank hold CRUS as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Cirrus Logic position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,366 Cirrus Logic shares in Q1 2025, an estimated $335K.
  • Alpha DNA Investment Management first reported a position in Cirrus Logic in Q4 2020 and held it in 5 quarters.
  • Alpha DNA Investment Management's Cirrus Logic position peaked at $1.41M in Q3 2021.
  • 436 funds tracked by Wall St. Rank held Cirrus Logic as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.